Sur, D., Havasi, A., Lungulescu, C., Volovat, S., Burz, C. and Irimie, A. 2022. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports. 95, 3 (May 2022), 251-259. DOI:https://doi.org/10.15386/mpr-2120.